Published online 22 March 2006
Article |
LINE-1 RNA splicing and influences on mammalian gene expression
Tulane Cancer Center, SL66 and Department of Epidemiology, Tulane University Health Sciences Center 1430 Tulane Ave., New Orleans, LA 70112, USA
*To whom correspondence should be addressed. Tel: +1 504 988 6385; Fax: +1 504 988 5516; Email: pdeinin{at}tulane.edu
Received December 27, 2005. Revised February 17, 2006. Accepted February 17, 2006.
Long interspersed element-1 elements compose on average one-fifth of mammalian genomes. The expression and retrotransposition of L1 is restricted by a number of cellular mechanisms in order to limit their damage in both germ-line and somatic cells. L1 transcription is largely suppressed in most tissues, but L1 mRNA and/or proteins are still detectable in testes, a number of specific somatic cell types, and malignancies. Down-regulation of L1 expression via premature polyadenylation has been found to be a secondary mechanism of limiting L1 expression. We demonstrate that mammalian L1 elements contain numerous functional splice donor and acceptor sites. Efficient usage of some of these sites results in extensive and complex splicing of L1. Several splice variants of both the human and mouse L1 elements undergo retrotransposition. Some of the spliced L1 mRNAs can potentially contribute to expression ofopen reading frame 2-related products and therefore have implications for the mobility of SINEs even if they are incompetent for L1 retrotransposition. Analysis of the human EST database revealed that L1 elements also participate in splicing events with other genes. Such contribution of functional splice sites by L1 may result in disruption of normal gene expression or formation of alternative mRNA transcripts.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. C. Hancks, A. D. Ewing, J. E. Chen, K. Tokunaga, and H. H. Kazazian Jr Exon-trapping mediated by the human retrotransposon SVA Genome Res., November 1, 2009; 19(11): 1983 - 1991. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Damert, J. Raiz, A. V. Horn, J. Lower, H. Wang, J. Xing, M. A. Batzer, R. Lower, and G. G. Schumann 5'-Transducing SVA retrotransposon groups spread efficiently throughout the human genome Genome Res., November 1, 2009; 19(11): 1992 - 2008. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Comeaux, A. M. Roy-Engel, D. J. Hedges, and P. L. Deininger Diverse cis factors controlling Alu retrotransposition: What causes Alu elements to die? Genome Res., April 1, 2009; 19(4): 545 - 555. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Shpiz, D. Kwon, Y. Rozovsky, and A. Kalmykova rasiRNA pathway controls antisense expression of Drosophila telomeric retrotransposons in the nucleus Nucleic Acids Res., January 1, 2009; 37(1): 268 - 278. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Akagi, J. Li, R. M. Stephens, N. Volfovsky, and D. E. Symer Extensive variation between inbred mouse strains due to endogenous L1 retrotransposition Genome Res., June 1, 2008; 18(6): 869 - 880. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Ichiyanagi and N. Okada Mobility Pathways for Vertebrate L1, L2, CR1, and RTE Clade Retrotransposons Mol. Biol. Evol., June 1, 2008; 25(6): 1148 - 1157. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. P. Belancio, D. J. Hedges, and P. Deininger Mammalian non-LTR retrotransposons: For better or worse, in sickness and in health Genome Res., March 1, 2008; 18(3): 343 - 358. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Muotri, M. C.N. Marchetto, N. G. Coufal, and F. H. Gage The necessary junk: new functions for transposable elements Hum. Mol. Genet., October 15, 2007; 16(R2): R159 - R167. [Abstract] [Full Text] [PDF]
|
|